<DOC>
	<DOCNO>NCT00419224</DOCNO>
	<brief_summary>The purpose study determine whether influenza vaccination protect patient receive certain type bone marrow transplantation .</brief_summary>
	<brief_title>Influenza Vaccination Bone Marrow Transplantation</brief_title>
	<detailed_description>Patients receive bone marrow transplantation high risk complication influenza infection . It whether influenza vaccination protect patient undergo type bone marrow transplantation call `` nonmyeloablative '' , `` reduce intensity '' bone marrow transplantation . This study compare response influenza vaccination group patient healthy people .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Patients include received RIC allo HSCT 3 month prior enrollment , age 18 65 year . Controls health care provider institution , age 18 65 year , good health , routinely offer influenza vaccination . Patients exclude failed engraft , relapse underlying disease require chemotherapy immunotherapy . Patients control also exclude history egg allergy , acute febrile illness time vaccination , influenzalike illness within 4 week prior vaccination .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>Peripheral blood stem cell transplantation</keyword>
	<keyword>Non-myeloabalative</keyword>
	<keyword>Influenza vaccination</keyword>
	<keyword>Humoral immune response</keyword>
	<keyword>Immunogenicity</keyword>
</DOC>